BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9310210)

  • 1. Impact of promotion of the Great American Smokeout and availability of over-the-counter nicotine medications, 1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Sep; 46(37):867-71. PubMed ID: 9310210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From the Centers for Disease Control and Prevention. Impact of promotion of the Great American Smokeout and availability of over-the-counter nicotine medications, 1996.
    JAMA; 1997 Dec; 278(23):2055-6. PubMed ID: 9403407
    [No Abstract]   [Full Text] [Related]  

  • 3. The benefits of switching smoking cessation drugs to over-the-counter status.
    Keeler TE; Hu TW; Keith A; Manning R; Marciniak MD; Ong M; Sung HY
    Health Econ; 2002 Jul; 11(5):389-402. PubMed ID: 12112489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Over-the-counter nicotine replacement therapy: a methodological review of the evidence supporting its effectiveness.
    Walsh RA
    Drug Alcohol Rev; 2008 Sep; 27(5):529-47. PubMed ID: 18696300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promotion of nicotine replacement therapy and smoking cessation services at grocery stores.
    Williman J; Fernandes K; Walker N; Bullen C
    N Z Med J; 2011 Apr; 124(1333):65-7. PubMed ID: 21750600
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of over-the-counter sales of the nicotine patch and nicotine gum on smoking cessation in California.
    Reed MB; Anderson CM; Vaughn JW; Burns DM
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2131-6. PubMed ID: 16172221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of the 2006 Scottish smoke-free legislation on sales of nicotine replacement therapy.
    Lewis SA; Haw SJ; McNeill A
    Nicotine Tob Res; 2008 Dec; 10(12):1789-92. PubMed ID: 19023830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of FDA-approved pharmacologic treatments for tobacco dependence--United States, 1984-1998.
    Burton SL; Gitchell JG; Shiffman S;
    MMWR Morb Mortal Wkly Rep; 2000 Jul; 49(29):665-8. PubMed ID: 10943254
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship between adherence to daily nicotine patch use and treatment efficacy: secondary analysis of a 10-week randomized, double-blind, placebo-controlled clinical trial simulating over-the-counter use in adult smokers.
    Shiffman S; Sweeney CT; Ferguson SG; Sembower MA; Gitchell JG
    Clin Ther; 2008 Oct; 30(10):1852-8. PubMed ID: 19014840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ten years after the Rx-to-OTC switch of nicotine replacement therapy: what have we learned about the benefits and risks of non-prescription availability?
    Shiffman S; Sweeney CT
    Health Policy; 2008 Apr; 86(1):17-26. PubMed ID: 17935827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of selectors of nicotine replacement therapy.
    Shiffman S; Di Marino ME; Sweeney CT
    Tob Control; 2005 Oct; 14(5):346-55. PubMed ID: 16183986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy for tobacco dependence.
    Fant RV; Buchhalter AR; Buchman AC; Henningfield JE
    Handb Exp Pharmacol; 2009; (192):487-510. PubMed ID: 19184660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are instructions for over-the-counter nicotine replacement therapy products readable?
    Stevens AB; McDaniel KS; Glover ED; Wallace LS
    Am J Health Behav; 2007; 31 Suppl 1():S79-84. PubMed ID: 17931140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Accessibility of nicotine substitution products and prevention of cancers].
    Le Houezec J
    Rev Mal Respir; 1999 Jan; 16 Suppl 3():S194-5. PubMed ID: 10088318
    [No Abstract]   [Full Text] [Related]  

  • 15. Cautions and warnings on the US OTC label for nicotine replacement: what's a doctor to do?
    Zapawa LM; Hughes JR; Benowitz NL; Rigotti NA; Shiffman S
    Addict Behav; 2011 Apr; 36(4):327-32. PubMed ID: 21220188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoking cessation practices of Dutch general practitioners, cardiologists, and lung physicians.
    Kotz D; Wagena EJ; Wesseling G
    Respir Med; 2007 Mar; 101(3):568-73. PubMed ID: 16890419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Off-label prescribing of the nicotine patch for psychiatric patients.
    Scharf D
    Can Nurse; 2009 Nov; 105(9):12, 14. PubMed ID: 19998689
    [No Abstract]   [Full Text] [Related]  

  • 19. Misuse of and dependence on over-the-counter nicotine gum in a volunteer sample.
    Hughes JR; Pillitteri JL; Callas PW; Callahan R; Kenny M
    Nicotine Tob Res; 2004 Feb; 6(1):79-84. PubMed ID: 14982691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of varenicline for smoking cessation.
    Hays JT; Ebbert JO; Sood A
    Am J Med; 2008 Apr; 121(4 Suppl 1):S32-42. PubMed ID: 18342165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.